(PRWEB) November 28, 2012
The Fresenius Medical Care (FMC) dialysis products GranuFlo and NaturaLyte may cause up to a six-fold increase for cardiopulmonary arrest and sudden cardiac death, according to The New York Times. Even more disturbing is that FMC was aware of the dangers associated with GranuFlo and NaturaLyte but hid information about patient safety hazards in order to put profits ahead of patient safety, reports The Times. This egregious conduct has placed more than 50% of all dialysis patients in the United States at risk for cardiac complications. It is estimated that over 3,000 dialysis clinics treating more than 250,000 dialysis patients may still be using these potentially dangerous products.
An FDA investigation against FMC led to the Class I recall of GranuFlo and NaturaLyte on June 27, 2012. It is incredulous that FMC executives knew about the increased risk of cardiac arrest and death associated with GranuFlo since at least 2010 as indicated by the internal memo reported by The Times. Even more disturbing is that this information was held at the corporate level for 15 months before it was shared even to Fresenius’ own operating clinics, let alone the unsuspecting Public.
Who May Qualify for Compensation?
Cardiac death is recognized as the number one cause of death for dialysis patients. The use of the FMC products, GranuFlo and/or NaturaLyte exacerbate this problem by causing high bicarbonate levels which may result in metabolic alkalosis- a risk associated with low blood pressure, hypokalemia, hypoxemia, cardiac arrhythmia, cardiopulmonary arrest and death according to the FDA's recall notice.
If you or a loved one have received the GranuFlo and/or NaturaLyte product and suffered one of the following complications within 48 hours of receiving the product, you may be entitled to compensation:
- Cardiopulmonary arrest
- Heart problems
- Metabolic alkalosis
- Sudden MI or heart attack
- Stroke, and/or
How to Hire an Attorney
Hiring an attorney is not a difficult or expensive experience. Attorneys handling personal injury litigation as described above work on a contingency fee agreement. This means the attorney receives a percentage of the recovery received in the litigation. If there is no recovery by the client, there are no fees or costs charged to the client. Consultations to determine whether a client has a case are also free. To assist you and your attorney in determining whether you have a claim, below are the serial numbers for the defective GranuFlo and NaturaLyte products:
OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B, OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B, OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B
08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-1
Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who was injured by the GranuFlo or NaturaLyte products by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation form.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies and medical device makers.